1. Home
  2. STTK vs MYFW Comparison

STTK vs MYFW Comparison

Compare STTK & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STTK
  • MYFW
  • Stock Information
  • Founded
  • STTK 2016
  • MYFW 2002
  • Country
  • STTK United States
  • MYFW United States
  • Employees
  • STTK N/A
  • MYFW N/A
  • Industry
  • STTK Biotechnology: Pharmaceutical Preparations
  • MYFW Major Banks
  • Sector
  • STTK Health Care
  • MYFW Finance
  • Exchange
  • STTK Nasdaq
  • MYFW Nasdaq
  • Market Cap
  • STTK 37.6M
  • MYFW 201.1M
  • IPO Year
  • STTK 2020
  • MYFW 2018
  • Fundamental
  • Price
  • STTK $0.85
  • MYFW $23.13
  • Analyst Decision
  • STTK Hold
  • MYFW Buy
  • Analyst Count
  • STTK 4
  • MYFW 2
  • Target Price
  • STTK $3.00
  • MYFW $24.25
  • AVG Volume (30 Days)
  • STTK 398.2K
  • MYFW 49.5K
  • Earning Date
  • STTK 07-31-2025
  • MYFW 07-22-2025
  • Dividend Yield
  • STTK N/A
  • MYFW N/A
  • EPS Growth
  • STTK N/A
  • MYFW 154.12
  • EPS
  • STTK N/A
  • MYFW 1.04
  • Revenue
  • STTK $4,606,000.00
  • MYFW $91,514,000.00
  • Revenue This Year
  • STTK N/A
  • MYFW $17.24
  • Revenue Next Year
  • STTK N/A
  • MYFW $10.85
  • P/E Ratio
  • STTK N/A
  • MYFW $22.23
  • Revenue Growth
  • STTK 69.65
  • MYFW 13.99
  • 52 Week Low
  • STTK $0.69
  • MYFW $15.54
  • 52 Week High
  • STTK $4.99
  • MYFW $23.85
  • Technical
  • Relative Strength Index (RSI)
  • STTK 40.01
  • MYFW 68.47
  • Support Level
  • STTK $0.77
  • MYFW $22.33
  • Resistance Level
  • STTK $0.91
  • MYFW $22.75
  • Average True Range (ATR)
  • STTK 0.08
  • MYFW 0.68
  • MACD
  • STTK -0.03
  • MYFW 0.19
  • Stochastic Oscillator
  • STTK 19.95
  • MYFW 79.78

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

Share on Social Networks: